Forecasts and Analysis by Therapeutics (GFT 505, Obeticholic Acid (INT-747), Simtuzumab and Liraglutide (Victoza), Vitamin E, Pioglitazone, Placebo) and Region.
Report Details • Do you need definitive NASH market data? • Succinct NASH market analysis? • Technological insight? • Actionable business recommendations?
Read on to discover how this definitive report can transform your own research and save you time. The increase in prevalence of hepatic pathology and its pathophysiology have propelled the growth of the novel therapeutic studies, which has given birth to the novel therapeutic solutions such as Farnesoid X Receptor (FXR) agonists, incretins and probiotics. Most of these studies are in last phase of their clinical trials and commercialization is expected within a short period of time that could be used in treating patients with NASH.
Report highlights • 132 quantitative tables, charts, and graphs across 145 pages • Global NASH market outlook and analysis from to 2027 • Global NASH submarket forecasts and analysis from to 2027 • GFT 505 • Obeticholic Acid (INT-747) • Simtuzumab and Liraglutide (Victoza) • Vitamin E • Pioglitazone • Placebo • Regional and National NASH market forecasts to 2027
North America forecast to 2027: • US forecast to 2027 • Canada forecast to 2027 • Mexico forecast to 2027
South America forecast to 2027: • Brazil forecast to 2027 • Argentina forecast to 2027 • Paraguay forecast to 2027 • Bolivia forecast to 2027 • Rest of South America forecast to 2027
Europe forecast to 2027: • Germany forecast to 2027 • UK forecast to 2027 • France forecast to 2027 • Italy forecast to 2027 • Spain forecast to 2027 • Rest of Europe forecast to 2027 • Asia-Pacific forecast to 2027 • Japan forecast to 2027 • India forecast to 2027 • China forecast to 2027 • Australia forecast to 2027 • Thailand forecast to 2027 • Rest of Asia-Pacific forecast to 2027
Rest of World forecast to 2027: • Middle East forecast to 2027 • Africa forecast to 2027 • Other Countries forecast to 2027
Key questions answered • What does the future hold for the Pharmaceutical industry with regards to Nonalcoholic Steatohepatitis (NASH) • Where should you target your business strategy? • Which applications should you focus upon? • Which disruptive technologies should you invest in? • Which companies should you form strategic alliances with? • Which company is likely to success and why? • What business models should you adopt? • What industry trends should you be aware of?
KEY FINDINGS The global market for viral vector vaccines is expected to grow at a CAGR of 18.19% over the forecast period of 2019-2027. Promising results from several clinical studies performed by various organizations have emphasized the potential of viral-vector-based vaccines and therapies for gene therapies. MARKET...
The global drug of abuse testing market is projected to cross US$ 5 Billion by 2024. Drugs of abuse testing involves detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. The use of illicit drugs is increasing across the globe. According to the United Nations Office on Drugs and Crime, nearly...
111 pages •
By Infiniti Research Limited
• Oct 2018
About Sjogren’s Syndrome Sjogren’s syndrome is an autoimmune disorder and the major symptoms of this disorder are dry eyes and dry mouth. The mucous membranes produce reduced tears, and moisture-secreting glands in the mouth secrete smaller amounts of saliva. Technavio’s analysts forecast the Global Sjogren’s Syndrome...
110 pages •
By Infiniti Research Limited
• Oct 2018
About Diffuse Large B-Cell Lymphoma DLBCL is a cancer of B-lymphocytes. It is the most common type of NHL among adults. It is an aggressive (fast-growing), complex, and difficult-to-treat form of NHL, which refers to a group of cancers of the lymphatic system. Technavio’s analysts forecast the Global DLBCL Therapeutics...
Report Synopsis Personalized medicine has a huge potential in leading the healthcare industry with drastic changes with a key focus on diseases understanding & management integrated with advanced analytics, patient data, customized medicines and other possibilities. Personalized Medicine will transform the entire pharmaceutical...
The report presents a detailed analysis of the Aeromonads diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Aeromonads definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: